FINWIRES · TerminalLIVE
FINWIRES

中国製造業は4月に強化:PMIレポート

By

-- S&Pグローバルは木曜日、需要と生産量の増加に支えられ、中国の巨大な製造業が4月も5ヶ月連続で拡大したと発表した。 S&Pグローバルは月次調査を引用し、中国の製造業購買担当者景気指数(PMI)が4月に52.2に上昇し、3月の50.8から上昇、景気拡大と縮小の分岐点となる50をさらに上回ったと報告した。 S&Pグローバルによると、中東情勢の混乱にもかかわらず、中国の工場生産は「堅調な需要、操業改善、新製品投入に牽引され、約2年ぶりの速いペースで増加した」。 S&Pグローバルは、工場経営者らが新規受注が約5年ぶりの速いペースで増加したと報告しており、これは強い需要と革新的な新製品によるものだと説明した。 製造業者は4月に受注残高の増加を享受したが、特に投資財(資本財、すなわち企業で使用される機械設備)メーカーで顕著だった。 中国の工場経営者らは4月、エネルギー供給の停滞の兆候など、供給面でいくつかの課題に直面した。 「サプライチェーンへの圧力は依然として続いており、4月も原材料のリードタイムが再び長期化した」とS&Pグローバルは指摘した。経営者らは、原材料不足の継続、配送の遅延、原材料価格の高騰に加え、中東情勢の緊迫化がサプライチェーンの混乱を悪化させていると述べた。 S&Pグローバルによると、中国の製造業者は4月、原材料価格の上昇分をほぼ顧客に転嫁しており、経営者の景況感は同月に改善した。 4月の製造業PMIは、S&Pグローバルが4月9日から22日にかけて650社の製造業者に送付した調査に基づいて算出された。 一方、中国の公式PMIは4月に50.3となり、3月の12カ月ぶりの高水準である50.4からはやや低下したものの、2カ月連続で景気拡大圏を維持したと、国家統計局(NBS)が木曜日に発表した。

Related Articles

Research

Research Alert: Blue Owl Capital Reports Slight Distributable Earnings Beat And Aum Growth

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:OWL delivered Q1 2026 FRE of $0.25 vs $0.23 consensus and DE of $0.19 vs $0.18 consensus, with LTM FRE revenues up 13% and FRE up 14% Y/Y. AUM rose 15% Y/Y to $315B though sequential growth was limited by redemptions, while fee-paying AUM reached $188B, up 7% Y/Y. We believe OWL is well-positioned for the secular shift to private credit and is diversifying beyond its leading credit position across multiple debt financing categories. Management noted software loan balances represent only 8% of total AUM, addressing market concerns, but provided no specific financial guidance. The annual dividend increased 25% Y/Y to $0.90 per share in 2025, and the company repurchased 1.7M shares for $25M in Q1 2026. We expect positive AUM trends to continue as new capital raised was more than double fund distributions. Despite share price volatility from direct lending concerns, we would stay the course with OWL shares given strong fundamentals.

$OWL
Research

Research Alert: Bax Q1: Mixed Results Amid Operational Challenges And Transformation Efforts

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Baxter delivered mixed Q1 2026 results with sales of $2.7B (+3% reported, -1% organic) beating consensus by $80M, though organic decline highlighted execution issues. Adjusted EPS of $0.36 beat expectations by $0.05 but declined 35% Y/Y due to unfavorable expense timing and higher manufacturing costs. We view the persistent operational challenges across key divisions as concerning despite management's transformation efforts. Management reiterated full-year 2026 guidance of flat to 1% sales growth and adjusted EPS of $1.85-$2.05, emphasizing progress on the Baxter Growth and Performance System with 230+ Q1 initiatives. Segment performance remained mixed with Medical Products & Therapies generating $1.3B (+2% reported, -2% organic) hampered by infusion pump issues, while Pharmaceuticals provided strength at $621M (+7% reported). We believe the ongoing execution challenges underscore the complexity in stabilizing operations despite improved free cash flow of $76M vs. -$221M in the prior year.

$BAX
Research

Research Alert: Blue Owl Capital Reports Slight Distributable Earnings Beat And Aum Growth

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:OWL delivered Q1 2026 FRE of $0.25 vs $0.23 consensus and DE of $0.19 vs $0.18 consensus, with LTM FRE revenues up 13% and FRE up 14% Y/Y. AUM rose 15% Y/Y to $315B though sequential growth was limited by redemptions, while fee-paying AUM reached $188B, up 7% Y/Y. We believe OWL is well-positioned for the secular shift to private credit and is diversifying beyond its leading credit position across multiple debt financing categories. Management noted software loan balances represent only 8% of total AUM, addressing market concerns, but provided no specific financial guidance. The annual dividend increased 25% Y/Y to $0.90 per share in 2025, and the company repurchased 1.7M shares for $25M in Q1 2026. We expect positive AUM trends to continue as new capital raised was more than double fund distributions. Despite share price volatility from direct lending concerns, we would stay the course with OWL shares given strong fundamentals.

$OWL